News Conference News THT 2022 Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size Shelley Wood February 02, 2022
News Industry News Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2022 Shelley Wood January 31, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Daily News Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse Todd Neale January 21, 2022
News Daily News Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick Michael O'Riordan January 20, 2022
News Opinion Fellow Talk A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation Corbin E. Goerlich, MD January 13, 2022
News Daily News Using Donor Hearts After Circulatory Death Is Feasible for Transplantation Michael O'Riordan January 12, 2022
News Daily News With First-in-Human Porcine Heart Transplant, a New Chapter Begins Yael L. Maxwell January 11, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021
News Daily News Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients Todd Neale December 14, 2021
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Daily News Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF Caitlin E. Cox December 10, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021